Ee Leng Choong Email

R&D Operations Director . Specific Diagnostics

Current Roles

Employees:
50
Revenue:
$6.3M
About
Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specificᅢᄁ¬ツᆲ¬トᄁs Revealᅢᄁ¬ダᅡᄁ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specificᅢᄁ¬ツᆲ¬トᄁs unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specificᅢᄁ¬ツᆲ¬トᄁs system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing. Specific is located in Mountain View, California. For more information, visit www.specificdx.com. Corporate Contact, email: press@specificdx.com
Specific Diagnostics Address
855 Maude Ave.
Mountain View, CA
United States

Past Companies

Specific DiagnosticsR&D Operations Director
Valent BioSciencesRegulatory Specialist
IHMA, Inc.Scientific Quality Manager

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.